Bulletin from Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ)
October 9, 2019 – An Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) (“InDex” or the “Company”) took place on Wednesday, October 9, 2019 in the Company´s premises at Tomtebodavägen 23a in Stockholm, Sweden. At the Extraordinary General Meeting the following was resolved.Resolution to approve the Board of Directors’ resolution on a new issue of shares with deviation from the shareholders’ preferential rights In accordance with the Board of Directors’ proposal, the Extraordinary General Meeting resolved to approve the Board of Directors’ resolution on a new issue of